Davis Polk advised Taibang Biologic Group on the transaction. Taibang Biologic Group (previously listed as China Biologic Products Holdings on the Nasdaq Global Select Market under...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here